Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS: ACUR · Delayed Price · USD
0.0100
0.00 (0.00%)
Apr 19, 2024, 10:26 AM EDT - Market closed

Acura Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 1984
Net Income
0-1.08-1.66-3.95-3.84-5.68-7.39-4.99-13.21-13.9
Upgrade
Depreciation & Amortization
00.090.130.270.280.290.350.330.270.13
Upgrade
Share-Based Compensation
00.060.040.110.220.460.590.610.891.22
Upgrade
Other Operating Activities
-0.190.782.95-0.560.410.890.361-1.13
Upgrade
Operating Cash Flow
0-0.74-0.72-0.62-3.91-4.51-5.56-3.69-11.04-13.68
Upgrade
Capital Expenditures
000000-0.08-0.21-2.14-0.02
Upgrade
Acquisitions
0000000020
Upgrade
Change in Investments
-------10.87-7.35-6.54-21.5
Upgrade
Other Investing Activities
-----0.3121.757.676.6727.77
Upgrade
Investing Cash Flow
000000.3110.80.11-06.25
Upgrade
Common Stock Issued
0000.010407.8600
Upgrade
Share Repurchases
0-0-00000000
Upgrade
Other Financing Activities
-0.390.271.381.78-2.76-2.54-2.57-0.5212.29
Upgrade
Financing Cash Flow
00.390.271.391.781.24-2.545.29-0.5212.29
Upgrade
Net Cash Flow
0-0.35-0.450.77-2.13-2.962.71.71-11.574.86
Upgrade
Free Cash Flow
0-0.74-0.72-0.62-3.91-4.51-5.64-3.9-13.18-13.7
Upgrade
Free Cash Flow Margin
--47.47%-20.14%-23.26%-953.17%-152.06%-126.30%-45.44%-1754.86%-11139.02%
Upgrade
Free Cash Flow Per Share
--0.01-0.02-0.02-0.18-0.28-0.47-0.36-1.35-1.43
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.